Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces-Quad, Specify,
Medtronic Neuromodulation · Decision date Oct 30, 2026
What did the FDA decide?
FDA records P840001/S636 as a supplement to PMA P840001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 30, 2026.
FDA approval order statement
approval for the following three changes: 1) Adding a new surface mount technology (SMT) production line.2) Revision of the SMT manufacturing process sequence to perform automated optical inspection immediately following each SMT assembly stage.3) Addition of an equivalent solder paste inspection system and addition of a qualified de-paneling machine for PCBA production
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Oct 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P840001/S636
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- Decision code
- OK30
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.
- Applicant
- Medtronic Neuromodulation
- Product code
- LGW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P840001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P840001 · Original PMA
ITREL(R) TOTALLY IMPLANTABLE SPINAL CORD STIM. SYS
P840001/S634 · Related supplement
Vantawith AdaptiveStim Technology - Model 977006
P840001/S636 received
Application receipt date recorded by FDA.
P840001/S632 · Related supplement
Master Vanta with Restore, Itrel, Synergy, Intellis, AdaptiveStim Vanta and Inceptiv TM Spinal Cord Implantable S
P840001/S635 · Related supplement
Master Restore, Itrel, Synergy Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify,
P840001/S636 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P840001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P840001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Neuromodulation | PMA approval | Nov 30, 1984 | FDA | |
Vantawith AdaptiveStim Technology - Model 977006P840001/S634 | Medtronic Neuromodulation | PMA supplement | Sep 24, 2026 | FDA |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code LGW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
Saluda Medical Evoke SCS SystemP190002/S052 | Saluda Medical Pty, Ltd. | PMA supplement | Oct 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P840001/S636
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



